Insulin-like growth factor (igf) i mutant variants

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/65 (2006.01) A61K 38/30 (2006.01) A61P 13/12 (2006.01)

Patent

CA 2356109

IGF-I variants having an alanine, glycine, or serine amino acid residue at position 16, 25, 49 or at positions 3 and 49 of native-sequence IGF-I are provided that are useful to treat a disorder characterized by dysregulation of the GH/IGF axis in a mammal, such as a renal disorder.

L'invention concerne des variants de IGF-I qui possèdent un reste d'acide aminé d'alanine, glycine, ou sérine à l'emplacement 16, 25, 49 ou aux emplacements 3 et 49 de la séquence native de l'IGF-I. Lesdits variants sont utilisés pour traiter un trouble, tel qu'un trouble rénal, caractérisé par une dérégulation de l'axe hormone de croissance/IGF, chez un mammifère.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Insulin-like growth factor (igf) i mutant variants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulin-like growth factor (igf) i mutant variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin-like growth factor (igf) i mutant variants will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1640506

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.